Clinical trial
A Human Mass Balance Study of Pyronaridine Using Accelerator Mass Spectrometry
NCT01383109 is registered in ClinicalTrials.gov with Medicines for Malaria Venture as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Human Mass Balance Study of Pyronaridine Using Accelerator Mass Spectrometry
- Lead sponsor
- Medicines for Malaria Venture
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- June 30, 2011
- Completion date
- December 31, 2011
- Enrollment
- 6 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.